Matthew E Bender

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 7

Top Topics

Emergency Department

Brain Metastases

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Buse Eglenen-Polat, Ryan R Kowash, Hai-Cheng Huang, Silvia Siteni, Mingrui Zhu, Kenian Chen, Matthew E Bender, Ilgen Mender, Victor Stastny, Benjamin J Drapkin, Prithvi Raj, John D Minna, Lin Xu, Jerry W Shay, Esra A Akbay
A telomere-targeting drug depletes cancer initiating cells and promotes anti-tumor immunity in small cell lung cancer. Nature communications 15 (1) (2024)
Buse Eglenen-Polat, Ryan R Kowash, Hai-Cheng Huang, Silvia Siteni, Mingrui Zhu, Kenian Chen, Matthew E Bender, Ilgen Mender, Victor Stastny, Benjamin J Drapkin, Prithvi Raj, John D Minna, Lin Xu, Jerry W Shay, Esra A Akbay
A telomere-targeting drug depletes cancer initiating cells and promotes anti-tumor immunity in small cell lung cancer. Nature communications 15 (1) (2024)
Buse Eglenen-Polat, Ryan R Kowash, Hai-Cheng Huang, Silvia Siteni, Mingrui Zhu, Kenian Chen, Matthew E Bender, Ilgen Mender, Victor Stastny, Benjamin J Drapkin, Prithvi Raj, John D Minna, Lin Xu, Jerry W Shay, Esra A Akbay
A telomere-targeting drug depletes cancer initiating cells and promotes anti-tumor immunity in small cell lung cancer. Nature communications 15 (1) (2024)
Buse Eglenen-Polat, Ryan R Kowash, Hai-Cheng Huang, Silvia Siteni, Mingrui Zhu, Kenian Chen, Matthew E Bender, Ilgen Mender, Victor Stastny, Benjamin J Drapkin, Prithvi Raj, John D Minna, Lin Xu, Jerry W Shay, Esra A Akbay
A telomere-targeting drug depletes cancer initiating cells and promotes anti-tumor immunity in small cell lung cancer. Nature communications 15 (1) (2024)
Buse Eglenen-Polat, Ryan R Kowash, Hai-Cheng Huang, Silvia Siteni, Mingrui Zhu, Kenian Chen, Matthew E Bender, Ilgen Mender, Victor Stastny, Benjamin J Drapkin, Prithvi Raj, John D Minna, Lin Xu, Jerry W Shay, Esra A Akbay
A telomere-targeting drug depletes cancer initiating cells and promotes anti-tumor immunity in small cell lung cancer. Nature communications 15 (1) (2024)
Buse Eglenen-Polat, Ryan R Kowash, Hai-Cheng Huang, Silvia Siteni, Mingrui Zhu, Kenian Chen, Matthew E Bender, Ilgen Mender, Victor Stastny, Benjamin J Drapkin, Prithvi Raj, John D Minna, Lin Xu, Jerry W Shay, Esra A Akbay
A telomere-targeting drug depletes cancer initiating cells and promotes anti-tumor immunity in small cell lung cancer. Nature communications 15 (1) (2024)
Buse Eglenen-Polat, Ryan R Kowash, Hai-Cheng Huang, Silvia Siteni, Mingrui Zhu, Kenian Chen, Matthew E Bender, Ilgen Mender, Victor Stastny, Benjamin J Drapkin, Prithvi Raj, John D Minna, Lin Xu, Jerry W Shay, Esra A Akbay
A telomere-targeting drug depletes cancer initiating cells and promotes anti-tumor immunity in small cell lung cancer. Nature communications 15 (1) (2024)